<DOC>
	<DOCNO>NCT01874184</DOCNO>
	<brief_summary>This randomize clinical trial study group-based lifestyle intervention usual care measure biomarker level participant high risk breast cancer . Studying effect change daily eat exercise habit body 's hormone level body 's ability activate protein may help doctor identify intervention individual high risk breast cancer .</brief_summary>
	<brief_title>Group-Based Lifestyle Intervention Measuring Biomarker Levels Participants High Risk Breast Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To calculate eligibility rate , participation rate , retention , adherence within Diet , Exercise Estrogen Metabolites ( DEEM ) study . II . To determine inter- intra-person variability estrogen-deoxyribonucleic acid ( DNA ) adduct ( EDA ) biomarkers participant DFS . III . To explore effect intervention percent adiposity EDA ratio end 3-month intervention 6-month follow-up . SECONDARY OBJECTIVES : I . To explore effect intervention DNA damage repair ( DDR ) biomarker 3-months . OUTLINE : Participants randomize 1 2 arm . ARM I : Participants take part weekly 2-hour group counsel session 6 month taper begin 3 month . Group session include education , group process , experiential learn benefit physical activity , balance nutrition , mindfulness technique . Participants set goal change dietary habit help mental health counselor also encourage exercise 3-4 time per week , include experiential group activity brisk walking , yoga , Zumba , group fitness . ARM II : Participants receive usual care also provide study material healthy diet exercise end study . After completion study , participant follow 3 month .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Carcinoma , Ductal , Breast</mesh_term>
	<mesh_term>Carcinoma , Intraductal , Noninfiltrating</mesh_term>
	<mesh_term>Carcinoma , Lobular</mesh_term>
	<criteria>Women consider high risk develop breast cancer fulfill one follow criterion : A Gail model risk &gt; = 1.7 % 5 Claus model lifetime risk &gt; 20 % TyrerCuzick model lifetime risk &gt; 20 % Personal history breast biopsy show atypical ductal hyperplasia ( ADH ) , atypical lobular hyperplasia ( ALH ) lobular carcinoma situ ( LCIS ) Ductal carcinoma situ ( DCIS ) previously treat ; patient must least 2 month completion primary therapy currently hormonal therapy Deleterious mutation breast cancer ( BRCA ) 1 BRCA2 another gene know increase risk develop breast cancer Risk assessment 20 % chance great carry BRCA1/2 gene mutation ; BRCAPRO model use assess risk Body mass index ( BMI ) For postmenopausal woman : BMI &gt; 28 &lt; 40 For premenopausal woman : BMI &gt; 25 &lt; 40 Willingness provide inform consent Physically able undertake moderate exercise program ( assessed clinic visit ) Participant ability attend weekly group counsel session subsequent clinic visit Participant ability communicate English Participant agree randomly assign Women currently engage 90 min moderate vigorous exercise per week time recruitment Alcohol/drug abuse significant mental illness , assess study personnel Previous diagnosis invasive cancer within past 5 year ( situ breast cancer simple basal squamous cell carcinoma include ) Plans leave geographic area within six month Contraindications treadmill test entry train program Pregnant woman woman plan pregnant follow year admit study</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>